News

Quebec stops Oxford-AstraZeneca as a first dose, reports 781 new COVID-19 infections

Quebec stops Oxford-AstraZeneca as a first dose, reports 781 new COVID-19 infections
Canada
The Health Department said today people who have received AstraZeneca can choose whether to get a second dose of that vaccine or another available vaccine as a booster shot.

The Oxford-AstraZeneca vaccine has been linked to rare blood clots, with around one case reported in every 100,000 people vaccinated. The Health Department says the odds of blood clots are lower for the second dose — around one in 1,000,000.

Quebec is reporting 781 new cases of COVID-19 today and five more deaths attributed to the novel coronavirus, none of which occurred in the past 24 hours.

Health officials say hospitalizations dropped by 10, to 520, and 121 people were in intensive care, a drop of five.

Officials say 93,650 doses of vaccine were administered within the past 24 hours, for a total of 4,014,843; about 45 per cent of Quebecers have received at least one dose of vaccine.
Read more on Toronto Star
News Topics :
Similar Articles :
Health
MONTREAL Quebec is shortening the minimum time between first and second doses of the Oxford AstraZeneca COVID 19 vaccine to eight weeks, Health Minister Christian Dube announced Thursday. Second...
Top Stories
TORONTO Impatience and a lack of clarity persisted Thursday over the fate of thousands of doses of the Oxford AstraZeneca vaccine set to expire in the coming weeks....
Canada
Manitobans 40 and older will soon be able to get the Oxford AstraZeneca COVID 19 vaccine. The source, who spoke on condition of anonymity, says an announcement is to be made today....
Top Stories
MONTREAL Canada reported its first case of vaccine induced blood clots linked to the Oxford AstraZeneca vaccine in a Quebec woman who is now said to be recovering at...
Top Stories
Preliminary results of an ongoing study in the United Kingdom suggest alternating the Oxford AstraZeneca and Pfizer BioNTech vaccines causes more frequent mild to moderate symptoms, but there are no other safety...